TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Small To Medium Peptides, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Small To Medium Peptides technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Small To Medium Peptides

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Industry Landscape Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Last updated on: Jul 31, 2025
CompanyTotal Oppositions Filed
CARPMAELS & RANSFORD4
DEHNS1
EIP1
HOFFMANN EITLE1
MAIWALD1
MEWBURN ELLIS1
ROCHE1
UEXKULL & STOLBERG1

Patent challenges are becoming increasingly common in the Small To Medium Peptides industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Small To Medium Peptides industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Small To Medium Peptides industry

Variants Of C-Type Natriuretic PeptideBIOMARIN PHARMACEUTICALApr 10, 2025ASCENDIS PHARMA
Methods For Increasing Growth In Pediatric Subjects Having Cholestatic Liver DiseaseMIRUM PHARMACEUTICALSFeb 14, 2025SANDOZ
Compositions And Methods For Promoting Hemostasis And Other Physiological ActivitiesMASSACHUSETTS INSTITUTE OF TECHNOLOGYMar 6, 2024EIP
Variants Of C-Type Natriuretic PeptideBIOMARIN PHARMACEUTICALSep 1, 2022ASCENDIS PHARMA GROWTH DISORDERS
Sclerostin EpitopesUCB PHARMAJun 21, 2022JAMES POOLE
Absorbent Structure For Absorbent ArticlesTHE PROCTER & GAMBLEJul 23, 2020VON WESTERNHAGEN
Sprayable Topical Carrier And Composition Comprising PhosphatidylcholineLIPIDORMar 19, 2020BEIERSDORF
Targeted/Immunomodulatory Fusion Proteins And Methods For Making SameBIOCONFeb 28, 2019HOFFMANN EITLE
Compositions For Prevention Of Adhesions And Other Barrier ApplicationsARCH THERAPEUTICSFeb 22, 2018STRAWMAN
Sclerostin EpitopesUCB PHARMANov 22, 2017JAMES POOLE

To stay ahead in the competitive Small To Medium Peptides industry, companies are constantly innovating. Here are the top patents facing oppositions in the Small To Medium Peptides industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Oct 23, 2019Absorbent Structure For Absorbent ArticlesTHE PROCTER & GAMBLE2
Dec 1, 2021Variants Of C-Type Natriuretic PeptideBIOMARIN PHARMACEUTICAL2
Sep 22, 2021Sclerostin EpitopesUCB PHARMA1
Jun 7, 2017Compositions For Prevention Of Adhesions And Other Barrier ApplicationsARCH THERAPEUTICS1
May 30, 2018Targeted/Immunomodulatory Fusion Proteins And Methods For Making SameBIOCON1
Jul 6, 2022Sprayable Topical Carrier And Composition Comprising PhosphatidylcholineLIPIDOR1
Jun 7, 2023Compositions And Methods For Promoting Hemostasis And Other Physiological ActivitiesVERSITECH1
May 15, 2024Methods For Increasing Growth In Pediatric Subjects Having Cholestatic Liver DiseaseMIRUM PHARMACEUTICALS1
Dec 13, 2023Sclerostin EpitopesUCB PHARMA1